Efficacy and safety of immune checkpoint inhibitors combined with chemotherapy as first-line treatment for extensive-stage small cell lung cancer: a meta-analysis based on mixed-effect models

BACKGROUND: Extensive-stage small cell lung cancer (ES-SCLC) is a highly invasive and fatal disease with limited therapeutic options and poor prognosis. Our study aims to systematically evaluate the efficacy and safety of immune checkpoint inhibitors combined with chemotherapy (ICIs+ChT) vs. chemoth...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Jianqing, Deng, Yujie, Huang, Bifen, Chen, Xiaohui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424447/
https://www.ncbi.nlm.nih.gov/pubmed/37583422
http://dx.doi.org/10.3389/fmed.2023.1198950

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424447/
https://www.ncbi.nlm.nih.gov/pubmed/37583422
http://dx.doi.org/10.3389/fmed.2023.1198950

Ejemplares similares